---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-250665"
form_type: "8-K"
ticker: "KALV"
cik: "0001348911"
company_name: "KalVista Pharmaceuticals, Inc."
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T05:50:41.991514+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# KalVista raises $60M in public offering and private placement to fund sebetralstat

## Summary
- Public offering of 5.5M shares at $10.00 per share for gross proceeds of $55M; net ~$51.3M.
- Concurrent private placement of 500K shares to DRI Healthcare Acquisitions LP for $5M gross; net ~$4.7M.
- Proceeds will fund continued clinical development of sebetralstat and pre-commercialization activities.
- Offering and private placement expected to close November 5, 2024; closings not contingent on each other.
- Jefferies, BofA Securities, TD Cowen, and Stifel serving as joint book-running managers and placement agents.

## SEC filing metadata
- accession: 0001193125-24-250665
- form_type: 8-K
- ticker: KALV
- cik: 0001348911
- company_name: KalVista Pharmaceuticals, Inc.
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348911/000119312524250665/0001193125-24-250665-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348911/000119312524250665/d907269d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-250665
- JSON: https://secwatch.observer/filing/0001193125-24-250665.json
- Plain text: https://secwatch.observer/filing/0001193125-24-250665.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.